Share on Instagram  
Background Image

#iconohash presents #bcsm

Scroll down for the #bcsm conversation report for January 8th, 2020 EST.

iconohash

the world's conversation archive

#bcsm for January 8th, 2020 EST

01
75th

coming together

When it comes to participants, we ranked 75th among 412 conversations.

76th

participating

In terms of the number of posts, we ranked 76th out of 412 conversations that took place.

33rd

amplification

This conversation ranked 33rd out of 412 in terms of the amplification of ideas & content.

how we participated. Here's how participants reacted & engaged each other

Reactions
64%

Amplified

There were 34 reshares, 64% of posts, during the course of the conversation.

4%

Engaged

4% of participants in this conversation engaged each other 2 times.

28%

Content

28% of participants in this conversation shared a total of 5 unique pieces of content.

quick facts.

Here are the basic facts of the conversation for for January 8th, 2020.

0
Active
Participants
0
Posts
Total

meet the influencers the movers and shakers of #bcsm

02

the top of the list. Top influencers in the chat

IMPACT
@PJadeja16

@PJadeja16

Dr. Priya Jadeja
Breast Surgeon, Summit Medical Group-MD Anderson Cancer Center. Tweets are my own. Alum of Cleveland Clinic and Columbia Univ Medical Center.

@thebreastofus

@thebreastofus

forthebreastofus
A #breastcancer community for #womenofcolor

@BreastAdvocate

@BreastAdvocate

Breast Advocate
Free #BreastCancer #SharedDecisionMaking App for newly-diagnosed, Survivors, Thrivers & Previvors. Co-created by breast cancer specialists & patient advocates.

moving the conversation.

Without these participants, this conversation could not happen.

about the participants. let's take a look at everyone who show'd up

03

top professions what are they doing when they're not in #bcsm

insight

  the top participating professions
out of 12 total

research
professor
founder
oncologist
editor

gender an estimation of what the gender break down looks like
= 1 men or women

insight

Women

Men

about the content. the best content that was shared

04
FDA Approves Pembrolizumab for High-Risk NMIBC
The FDA has approved pembrolizumab for the treatment of patients with Bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer with carcinoma in situ with or without papillary tumors who are ineligible for or have elected not to undergo cystectomy.

chat growth how is #bcsm growing over time?

05

want more? are you interested in the full data analysis for this chat? Full transcript? Longer view at chat growth?

Order Report

Order a report now or request a custom report by emailing your request to research@iconohash.com. We'll be happy to work with you. We can provide the raw data or custom reports on a scheduled basis. Full data analysis includes in-depth profile data, chat growth analysis, chat reach, influence reach, location profiles, and content profiles.